9999999995-19-002036.txt : 20190909
9999999995-19-002036.hdr.sgml : 20190909
20190909001539
ACCESSION NUMBER: 9999999995-19-002036
CONFORMED SUBMISSION TYPE: EFFECT
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20190906
DATE AS OF CHANGE: 20190909
EFFECTIVENESS DATE: 20190906
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Akari Therapeutics Plc
CENTRAL INDEX KEY: 0001541157
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 981034922
STATE OF INCORPORATION: X0
FILING VALUES:
FORM TYPE: EFFECT
SEC ACT: 1933 Act
SEC FILE NUMBER: 333-233048
FILM NUMBER: 191080728
BUSINESS ADDRESS:
STREET 1: 24 WEST 40TH STREET
STREET 2: 8TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10018
BUSINESS PHONE: (646) 350-0702
MAIL ADDRESS:
STREET 1: 24 WEST 40TH STREET
STREET 2: 8TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10018
FORMER COMPANY:
FORMER CONFORMED NAME: Celsus Therapeutics Plc.
DATE OF NAME CHANGE: 20130621
FORMER COMPANY:
FORMER CONFORMED NAME: Morria Biopharmaceuticals PLC
DATE OF NAME CHANGE: 20120201
EFFECT
1
primary_doc.xml
X0101
EFFECT
33
LIVE
2019-09-06
16:30:00
0001541157
Akari Therapeutics Plc
333-233048